首页> 中文期刊> 《中西医结合心血管病电子杂志》 >康仁堂参附“全成分”配方颗粒治疗老年人肺心病并冠心病疗效观察

康仁堂参附“全成分”配方颗粒治疗老年人肺心病并冠心病疗效观察

         

摘要

目的:研究康仁堂参附“全成分”配方颗粒复方对老年人肺心病并冠心病的改善作用及疗效。方法选取2011年6月~2013年12月期间,在云南中医学院门诊部接受治疗的80例患者,随机分为治疗组合对照组。每组40例。对照组采用常规中药饮片治疗。疗程为4个疗程,治疗组采用参附配方颗粒进行治疗,两组患者采用不同药物治疗的临床效果进行观察比较。结果治疗组治疗总有效率92.5%。对照组为77.5%,两组总有效率比较差异无统计学意义(P>0.05)。结论康仁堂“全成分”参附配方颗粒与传统汤剂治疗老年人肺心病并冠心病均有疗效,但前者更具优势。%Objective To study Kangren Tang Shenfu"Ingredients"Improving the role of formula granule compound on pulmonary heart disease and coronary heart disease in the elderly and treatment. Methods June 2011-December 2013 period, Yunnan College clinic treated 80 patients were randomly divided into treatment combinations in the control group. Each group of 40 cases. Pieces of Chinese medicine control group with conventional therapy. For four courses of treatment, the treatment group were treated Shenfu formula particles, two patients with different clinical effects of drug treatment were observed and compared. Results The treatment group had 92.5%of the total efifciency. The control group was 77.5%, there is no difference between the two groups overall efifciency of statistical signiifcance (P>0.05). Conclusion Kangren Tang"Ingredients"Shenfu formula granule decoction to treat elderly patients with conventional pulmonary heart disease and coronary heart disease are effective, but the former advantages.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号